A Randomized, Double-blind, Placebo-controlled, Phase 1 Study to Assess the Safety, Tolerability, Preliminary Efficacy of Inhaled HH-120 Aerosol in Participants With Mild to Moderate COVID-19
Latest Information Update: 19 Sep 2023
At a glance
- Drugs HH-120 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors Huahui Health
Most Recent Events
- 19 Sep 2023 New trial record